VitaminCBD™ at War with COVID-19 The Influenza of

New Post Public Reply Private Reply Replies (1) Message Board
Kgem
281
VitaminCBD™ at War with COVID-19
The Influenza of 1918—The Face of Anxiety



102 Years ago, the world, planet earth was at war with its neighbors and the Spanish Flu was alive and well. I’m being a bit glib because that virus killed more people around the world than that long protracted world war. As a student of history, there is a great short story which tells the tale of two cities and how each reacted to that Pandemic and the parallels I want to make about VitaminCBD™ then and now.

The two cities were Philadelphia and St. Louis. This was 1918, and the influenza was raging around the world. There were ships pulling into the harbor of the Philadelphia port with sailors from other ports. There was a parade planned for liberty stamps to support the war. A number of public health officials recommended that this parade be canceled because of concerns about containment of this virus. It was determined by City Hall that the parade would go on, a major mistake. The day that St Louis had their first influenza death, quarantine of the city went into full effect. In Philadelphia, it took 14 days after its first death for Philadelphia to go into quarantine, second very, very big mistake.

The death rate for St Louis was 63 per one hundred thousand. Philadelphia’s death rate was 246 people per one hundred thousand. Bodies in Philadelphia were piled in the streets, big difference. I am not drawing a present day parallel to these two cities. I am mainly using this story to take us back to that space in time because COVID-19 is running our lives at the moment and there is another lesson to be learned from the past of how our grandparents and great grandparents weathered the storm of anxiety.

One in thirteen people around the world live with an anxiety disorder, making it the most common mental health disorder worldwide, according to the World Health Organization (WHO). For those living with anxiety, finding a safe method for managing symptoms is a critical concern.

If you’re curious about using VitaminCBD™ oil as a tool to help manage your anxiety, education is critical. Understanding the pros and cons of the various ingestion methods can help you determine which form of consumption best suits your needs and why it is important for the Endocannabinoid System (ECS). Yes, feeding the ECS is critical and most of us are deficient in the principal Cannabinoids (CBD, CBG, CBN).

However, after the 1937 prohibition on hemp, the Marijuana Tax Act of 1937 and the industrial revolution which resulted in over-farming of our lands, our exogenous phytocannabinoid supply fell into dietary neglect as our bodies make two phytocannabinoids, but often not enough.

As most scientists and clinicians will readily admit today, there is no universally recommended dosage for CBD, however, it is clear that phytocannabinoids (Cannabinoids) are necessary today, as much as in 1918, for our homeostatic ECS System which helps to balance our much-needed immune system. In 1918, hemp and its phytocannabinoid elements were part of our daily diet found in our food source.

To date, there haven’t been any large-scale clinical trials to inform dosage guidelines in supplying cannabinoids for the ECS. However, over the last seven years I continue to go with the concept of start slow and go low, 15mg/ml up to 50mg/ml is the starting range relative to body weight and pain level. In addition, the FDA is still learning about CBD—such as its cumulative effects on the body—before it decides on how to regulate it.

This doesn’t necessarily mean VitaminCBD™ is unsafe. Existing research already suggests that it appears to be a safe, well-tolerated treatment for longer than modern medicine. If you’re interested in experimenting with CBD to manage your anxiety symptoms with this War on COVID-19, - you can PM me and I will share my knowledge and my cautious approach to dosing (which is always a good idea). You can also go to www.VitaminCBD.life. I have experience from seed to formulation to sales of VitaminCBD™, and 40-plus years medical background so I can help!

We all know what it feels like to “stress out” before an exam or important event. But, sometimes a challenging job, family demands, or just surviving the unexpected events of life can feel like a continual test and now add Covid-19 to your equation. If that impending sense of disaster is never-ending, it's a sign of anxiety and supporting your ECS with VitaminCBD™ may be your answer as CBD was for your grandparents.

Authored by

Eric I. Mitchell MD MA FACPE CPE

Scroll down for more posts ▼

Top 10 Most Recent News Articles

TechCrunch Disrupt 2026: NYSE and Snowflake Highlights

Updated Category News Views 21

Ever noticed how the air vibrates just a bit more when major players like NYSE and Snowflake start shaking hands at big-league events like TechCrunch Disrupt? You'd better believe we're seeing a fresh brew of opportunities and challenges in the market as these titans lock horns and share insights. It's no small feat when the financial nerve center partners into the tech...

Continue Reading
Paradigm Therapeutics: A Beacon in Rare Diseases

Updated Category News Views 4

A Step Towards Recognition You know the old saying: innovation never sleeps. Well, Paradigm Therapeutics seems to have taken that to heart. The company's embarked on a peculiar yet promising journey with SD-101 (Zorblesia™), and here they are, basking in the glow of another nomination for the 2026 Prix Galien USA "Best Start-Up" award. It’s their second shot at this...

Continue Reading
Partner Valuation Advisors Bolsters Team with Eichman

Updated Category News Views 7

Eichman Joins Partner Valuation Advisors as MD Turns out the buzz in real estate appraisal isn’t just about property values these days; it's about who's valuing them. Just ask Partner Valuation Advisors, who are realigning their chess pieces by bringing seasoned pro Justin Eichman, MAI, on board as Managing Director. Talk about playing your cards right. A Heavyweight in...

Continue Reading
Skiptown Expands in Georgia Amid Growing Demand

Updated Category News Views 24

With the pet care industry barking up a storm lately, Skiptown is ramping up efforts to expand its presence in Georgia. The tech-enabled dog care franchise already has a paw print in Atlanta, but it's sniffing out new opportunities across the state. Now they're on the hunt for franchise owners who can bring this modern approach to more communities. Why Georgia? The Growth...

Continue Reading
Think Tank Pushes for Bold Parkinson's Prevention Plan

Updated Category News Views 25

A New Era for Parkinson's Disease Prevention The Parkinson's Foundation has rolled out its battle plan to take on Parkinson's disease from the ground up, shifting gears from managing symptoms to stopping the illness before it starts. It's about damn time, too. With the disease being the fastest-growing neurodegenerative disorder and impacting 10 million people worldwide,...

Continue Reading
Veterans Transitioning to Real Estate with Scholarships

Updated Category News Views 15

Tapping Military Skills for Civilian Gain Finding a new career after military service is a mountain of a task, but veterans now have a golden ticket into the real estate appraisal world. The Appraisal Institute's Next Mission Scholarship is throwing veterans a $1,000 life preserver to dive into a field where their military-honed skills already shine. The Power of a...

Continue Reading
Special Needs Group Partners with MAST to Enhance Accessibility

Updated Category News Views 22

Accessible Travel Takes the Spotlight Ah, the travel biz—just when you think you’ve got it all figured out, along comes a partnership like this to shake things up. Special Needs Group, the big cheese in mobility and medical equipment rentals, is teaming up with MAST Travel Network. Together, they're rolling out initiatives to make the world a bit more accessible, even...

Continue Reading
Omneky Outshines Competitors in AI Ad Scoring

Updated Category News Views 33

Brewing a better ad with AI isn't just about the model you plug in—it's about the wizardry wrapping around it. Omneky's latest caper in the AI advertising game has snagged the spotlight, pulling a hearty 8.8 taste score on a recent TasteBench comparison. That's not a minor tweak, folks, but a whopping 1.2-point lead over the shadow-chasing curves of the next...

Continue Reading
New Data on SKYRIZI Offers Hope for Crohn's Patients

Updated Category News Views 16

Treating Crohn's: New Hope on the Horizon Folks, let me tell you, the landscape for treating Crohn's disease just got a bit more interesting. AbbVie's Phase 3 AFFIRM study has brought some attention-grabbing data on the table, showcasing the potential of their drug, SKYRIZI® (risankizumab-rzaa). This ain't just another run-of-the-mill study; these results could be a...

Continue Reading
Honeywell Aerospace Faces Legal Turbulence in Fraud Case

Updated Category News Views 7

If you've got your chips on Honeywell Aerospace, Inc. (HONA), buckle up because things are getting choppy. Investors who took a bath on their shares now have the chance to put on their legal gloves and join a securities fraud class action lawsuit against the company. Legal Storm Over Misleading Statements Here's the rub: Between June 29 and September 1, 2026, the folks at...

Continue Reading

Top 5 Most Recently Viewed Articles

Pieridae Energy Limited Reports Strong Q3 2024 Performance

Updated Category News Views 58

Strong Financial and Operational Results from Pieridae Energy CALGARY, Alberta - Pieridae Energy Limited (“Pieridae” or the “Company”) (TSX: PEA) has announced its third quarter 2024 financial and operating results, showcasing an impressive production output and robust financial performance. The company achieved a production rate of 23,116 barrels of oil...

Continue Reading
Atea Pharmaceuticals Showcases Promising HCV Treatment Data

Updated Category News Views 136

Innovation in Hepatitis C Treatment by Atea Pharmaceuticals Atea Pharmaceuticals, Inc. (NASDAQ: AVIR) has made a significant impact in the field of antiviral therapeutics through their ongoing research and development efforts. The company recently presented compelling data at The Liver Meeting 2024, highlighting the promising combination of bemnifosbuvir and ruzasvir for...

Continue Reading
Study Confirms Safety of Combined Eye Drops for Surgery Use

Updated Category News Views 172

Introduction to the Study A five-year pharmacovigilance study has confirmed the excellent safety profile of a fixed-dose combination eye drop developed by NTC. This eye drop combines an anti-inflammatory steroid and a quinolone antibiotic, designed for preventing and treating inflammation, as well as preventing infection after cataract surgery. Study Overview The findings...

Continue Reading
New Concerns Arise for Roblox Amid Allegations of Misreported Metrics

Updated Category News Views 203

Allegations Against Roblox: A Closer Look Roblox Corp (NYSE: RBLX) has recently come under fire after a report from Hindenburg Research highlighted potential discrepancies in its reported user metrics, leading to a notable decline in its stock prices. The gaming platform is being questioned for allegedly overstating its user metrics, including daily active users (DAUs)...

Continue Reading
uniQure N.V. Faces Investigation Amid Securities Fraud Concerns

Updated Category News Views 155

Understanding the uniQure N.V. Investigation Currently, uniQure N.V. is under investigation concerning possible violations of securities laws. This inquiry has raised significant concerns for shareholders and potential investors, driving many to seek assistance in understanding their rights moving forward. The investigation is being led by the DJS Law Group, an...

Continue Reading